The relationship between HbA1c control pattern and atherosclerosis progression of diabetes: a prospective study of

Kun Li1,2, Longyan Yang3,4, Dong Zhao5,6

  • 1Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China.

Insights

Glycosylated hemoglobin (HbA1c) variability is linked to atherosclerosis progression in type 2 diabetes. Maintaining stable blood glucose levels is crucial for managing diabetes complications and preventing cardiovascular issues.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Syndrome

Background:

  • Glycosylated hemoglobin (HbA1c) control patterns are critical for managing type 2 diabetes.
  • Understanding the link between HbA1c variability and atherosclerosis progression is essential for preventing diabetes complications.

Purpose of the Study:

  • To comprehensively explain glycosylated hemoglobin (HbA1c) control patterns in type 2 diabetes.
  • To determine the causal relationship between glycemic control patterns and atherosclerosis progression.
  • To contribute to effective management strategies for diabetes complications.

Main Methods:

  • Analysis of HbA1c variability and trajectory groups in 1041 type 2 diabetes patients.
  • Examination of associations between HbA1c patterns and intima-media thickness (IMT) changes using multiple linear regression.
  • Application of a cross-lagged panel model (CLPM) to verify the bidirectional relationship between IMT and HbA1c.

Main Results:

  • HbA1c variability, excluding average real variability (ARV), was associated with intima-media thickness (IMT) changes (P < 0.05).
  • Four distinct HbA1c trajectories were identified; moderate-increase, U-shape, and relative high trajectories showed significantly higher IMT changes compared to the low-stable group.
  • Significant bidirectional associations were found between HbA1c and IMT after covariate adjustment.

Conclusions:

  • Four discrete HbA1c trajectory groups were identified during long-term diabetes follow-up.
  • A positive association exists between HbA1c variability and atherosclerosis progression.
  • Patients with diabetes should aim for stable blood glucose levels to avoid adverse cardiovascular outcomes.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920